For Immediate Release:
DNA Software Inc. to release PanelPlexTM
Infectious disease molecular diagnostic(MDx) assays require rapid identification of pathogens and their drug resistance profiles in clinical samples use a highly multiplexed molecular approach. The market pull for such MDx Read more ›
ANN ARBOR, MICH. – At its annual meeting, Ann Arbor SPARK presented its annual FastTrack awards to 17 Washtenaw County-based companies that have demonstrated fast growth. Several of the 2016 and 2017 FastTrack award recipients were multiple year winners.
“It’s Read more ›
Rice University group publishes on universal microbial diagnostics (UMD) recently in Science Advances Read more ›
Better Antisense Design Without the Trial and Error: Problems we Solve
Most researchers use naïve strategies to design antisense oligonucleotides. However, to maximize assay sensitivity and specificity one must consider probe and target sequence and their respective and combined chemistries. Read more ›
We recently spoke with a customer who was sharing with us the trials and tribulations of developing a multiplex PCR assay with multiple experimental iterations, at least a half dozen. When we starting asking clarifying questions, and we were surprised Read more ›
InSilixa Inc. and DNA Software Inc. enter into agreement to develop state-of-the-art high-multiplex infectious disease panels for commercialization on InSilixa’s CMOS biochip platform
03/10/2016 See press coverage at Genome Web
Infectious disease molecular diagnostic (MDx) assays developed specifically for InSilixa’s Read more ›
How do you design a successful multiplex PCR?
This question has been a common theme among DNAS customers since our inception 15 years ago. Whether the multiplex is used as a molecular diagnostic or for gene enrichment libraries for NGS, Read more ›